BCL2 and B-cell chronic lymphocytic leukemia: A classic example of this disruption has been observed in chronic lymphocytic leukaemia (CLL), where Bcl-2 mutations inhibit apoptosis, ultimately leading to increased survival and chemoresistance in CLL cells [88].